Difference between revisions of "2013-11-21 TSC UDI Task Force"

From HL7 TSC
Jump to navigation Jump to search
 
Line 9: Line 9:
 
| width="0%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 TSC Meeting Minutes''' <br/>
 
| width="0%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 TSC Meeting Minutes''' <br/>
 
'''Location: https://global.gotomeeting.com/join/134453157  
 
'''Location: https://global.gotomeeting.com/join/134453157  
| width="0%" colspan="1" align="left" style="background:#f0f0f0;"|'''Date: 2013-11-21'''<br/> '''Time: 4:00 PM U.S. Eastern DAYLIGHT'''
+
| width="0%" colspan="1" align="left" style="background:#f0f0f0;"|'''Date: 2013-11-21'''<br/> '''Time: 4:00 PM U.S. Eastern '''
 
|-
 
|-
 
| width="0%" colspan="2" align="right"|'''Facilitator''': Paul Knapp
 
| width="0%" colspan="2" align="right"|'''Facilitator''': Paul Knapp
Line 19: Line 19:
 
|-
 
|-
 
|colspan="2"|Attendee ||role
 
|colspan="2"|Attendee ||role
|- <!--
+
|-  
|x||Paul Ashford||ICCBBA
 
|-
 
 
|x ||Nagesh Bashyam||Drajer
 
|x ||Nagesh Bashyam||Drajer
 
|-  
 
|-  
|x||Hans Buitendijk||Siemens
+
| x||Hans Buitendijk||Siemens
 
|-
 
|-
 
|x ||Todd Cooper  ||DEV cochair
 
|x ||Todd Cooper  ||DEV cochair
 
|-
 
|-
| ||Pat Distler|| HIBC
+
|x||Erin Fields|| FDA
|-
 
|x||Pat Fields|| FDA
 
|-
 
|x|| Julian Goldman
 
|-
 
| x||Matt Graham ||Mayo, Mobile Health cochair
 
|-
 
| ||Grahame Grieve ||FHIR FMG, MnM
 
 
|-
 
|-
 
|regrets 11/21 ||Christian Hay ||GS1
 
|regrets 11/21 ||Christian Hay ||GS1
 
|-
 
|-
 
|x || Wendy Huang||CGIT
 
|x || Wendy Huang||CGIT
|-
 
|x|| Anne Kling ||Mitre
 
 
|-
 
|-
 
|x ||Paul Knapp ||FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
 
|x ||Paul Knapp ||FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
Line 49: Line 37:
 
|-  
 
|-  
 
|x||Brett Marquard||SDWG
 
|x||Brett Marquard||SDWG
 
 
|-
 
|-
|x||Ken McCaslin||Quest
+
|x ||John Moehrke|| GE
 
|-
 
|-
|x ||Behnaz Minaei ||FDA
+
| x ||JDL Nolen ||
|-
 
|x ||Matt Rahn || ONC
 
 
|-
 
|-
 
|x||Brian Pech||KP
 
|x||Brian Pech||KP
Line 63: Line 48:
 
|x ||John Rhoads ||cochair DEV
 
|x ||John Rhoads ||cochair DEV
 
|-
 
|-
| x||Paul Schluter ||with DEV and liaise with Continua and IHE PCP
+
|x ||Scott Robertson||Pharmacy co-chair
|-
 
| ||Tania Snioch||GS1 Australia
 
 
|-
 
|-
| ||Pat Van Dyke ||EHR cochair, ADentalA liaison
+
|x||Tania Snioch||GS1 Australia
 
|-
 
|-
| || Pele Yu ||Child Health
+
| x||Pat Van Dyke ||EHR cochair, ADentalA liaison
|- -->
 
 
|-
 
|-
 
|colspan="3" style="background:#f0f0f0;"|
 
|colspan="3" style="background:#f0f0f0;"|
Line 89: Line 71:
  
 
===Minutes===
 
===Minutes===
'''Minutes/Conclusions Reached:'''<br/>
+
'''Minutes/Conclusions Reached:'''<br/> convened at 4:08 PM
 +
#Roll Call
 +
#* Paul reviews the [http://gforge.hl7.org/gf/download/docmanfileversion/7685/11177/%46%44%41%2d%55%44%49%20%49%64%65%6e%74%69%66%69%65%72%73%20%32%30%31%33%31%31%31%34%2e%78%6c%73%78 design spreadsheet]
 +
#**document with the harmonized pattern also reviewed
 +
#**supplemental serial number as second serial number or business case for serial + lot number - cannot confirm with no representatives on today's call.
 +
#**Nagesh asks about cardinality of udi vs di. DI is the mandatory part of the udi and the FDA would like to see users validate the DI.
 +
#**Austin notes that the pattern is referring to V3 datatypes but needs to be conceptual across paradigms.
 +
#Next steps
 +
#*Paul will send the updated pattern document around for suggestions.  Paradigm specific areas can create addenda to specify representation in V2, V3, etc.
 +
#*Bring the addenda together with the pattern and have a call in a few weeks on Dec 12th
 +
#*Once the document is signed off it can go to an out of cycle harmonization.
 +
# Adjourn 5:02 PM
 +
 
 
   
 
   
  
Line 99: Line 93:
 
|-
 
|-
 
|colspan="4" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|colspan="4" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*TBD.
+
*[[2013-12-12 TSC UDI Task Force]].
 
|}
 
|}
  
  
 
© 2013 Health Level Seven® International.  All rights reserved.
 
© 2013 Health Level Seven® International.  All rights reserved.

Latest revision as of 22:06, 21 November 2013

TSC UDI TF

Meeting Info/Attendees

HL7 TSC Meeting Minutes

Location: https://global.gotomeeting.com/join/134453157

Date: 2013-11-21
Time: 4:00 PM U.S. Eastern
Facilitator: Paul Knapp Note taker(s): Lynn Laakso
Quorum not defined
Attendee role
x Nagesh Bashyam Drajer
x Hans Buitendijk Siemens
x Todd Cooper DEV cochair
x Erin Fields FDA
regrets 11/21 Christian Hay GS1
x Wendy Huang CGIT
x Paul Knapp FTSD co-chair, UDI Task Force Chair, ITS and FM cochairs, FMG
x Austin Kreisler TSC
x Brett Marquard SDWG
x John Moehrke GE
x JDL Nolen
x Brian Pech KP
x Terrie Reed FDA informatics and ONC with UDI incorporation into certification activities
x John Rhoads cochair DEV
x Scott Robertson Pharmacy co-chair
x Tania Snioch GS1 Australia
x Pat Van Dyke EHR cochair, ADentalA liaison

Agenda

  1. Roll Call
  2. Review draft agenda
  3. Task Force
    Definition: a purpose tasked committee with a lifetime to match the issue
    Objectives: to define a conceptual model for UDI to ensure interoperable implementation across the suite of HL7 standards (v2, v3 message4, v3 CDA, FHIR
    Goals for today:
  4. Next steps
  5. Adjourn


Minutes

Minutes/Conclusions Reached:
convened at 4:08 PM

  1. Roll Call
    • Paul reviews the design spreadsheet
      • document with the harmonized pattern also reviewed
      • supplemental serial number as second serial number or business case for serial + lot number - cannot confirm with no representatives on today's call.
      • Nagesh asks about cardinality of udi vs di. DI is the mandatory part of the udi and the FDA would like to see users validate the DI.
      • Austin notes that the pattern is referring to V3 datatypes but needs to be conceptual across paradigms.
  2. Next steps
    • Paul will send the updated pattern document around for suggestions. Paradigm specific areas can create addenda to specify representation in V2, V3, etc.
    • Bring the addenda together with the pattern and have a call in a few weeks on Dec 12th
    • Once the document is signed off it can go to an out of cycle harmonization.
  3. Adjourn 5:02 PM


Next Steps

Actions (Include Owner, Action Item, and due date)
  • .
Next Meeting/Preliminary Agenda Items


© 2013 Health Level Seven® International. All rights reserved.